期刊文献+

洋葱伯克霍尔德菌的临床分布及耐药性分析 被引量:6

The analysis of the clinical distribution and drug resistance of Burkholderia Cepacia
下载PDF
导出
摘要 目的了解2009-2010年东莞市石龙博爱医院临床分离的洋葱伯克霍尔德菌的标本来源、临床分布和耐药性,为控制院内感染提供依据。方法采用ATB Expression细菌鉴定仪和纸片扩散法对东莞市石龙博爱医院临床分离的洋葱伯克霍尔德菌进行鉴定和药敏试验。结果 2009-2010年共分离出62株洋葱伯克霍尔德菌,痰标本中分离菌株数占96.8%(60/62),主要来自于重症监护病房,占95.2%(59/62)。药敏试验结果显示,氨基糖苷类、喹诺酮类和亚胺培南的耐药率较高,均在80.0%以上;哌拉西林、哌拉西林/他唑巴坦和复方新诺明的耐药率较低,均在10.0%左右。结论洋葱伯克霍尔德菌对多种抗菌药物具有较高的耐药性,临床治疗应根据抗菌药物敏感性为依据。 Objective To investigate the source,clinical distribution and drug resistance of clinically isolated Burkholderia Cepacia specimens in our hospital from 2009 to 2010,and to provide basis for the preventing of infections in hospital.Methods The ATB expression bacterial identification system and K-B agar diffusion method were used to identify and test the drug sensitivity of the isolated Burkholderia Cepacia in our hospital.Results 62 strains Burkholderia Cepacia were isolated from 2009 to 2010,in which sputum accounted for 96.8%(60/62).Most of them came from the ICU,accounted for 95.2%(59/62).Drug resistance test results showed that the resistance rate of aminoglycosides,fluoroquinolones and imipenem had higher drug sensitivity rate(over 80%);while the drug resistance rate of piperacillin,piperacillin / tazobactam and cotrimoxazole were lower than 10%.Conclusion Burkholderia cepacia has a high resistance rate to many antimicrobial drugs.Clinical treatment should be based on the result of antimicrobial susceptibility.
出处 《检验医学与临床》 CAS 2011年第21期2591-2592,共2页 Laboratory Medicine and Clinic
关键词 洋葱伯克霍尔德菌 耐药性 医院感染 burkholderia cepacia drug resistance hospital infection
  • 相关文献

参考文献7

二级参考文献37

共引文献105

同被引文献71

  • 1杨宝财,董胜峰,孙莉,黄照国,李鲜爱,崔幸琨,时东彦.2009-2013年临床分离洋葱伯克霍尔德菌耐药现状[J].医药导报,2015,34(S01):133-134. 被引量:4
  • 2朱焱,明德松,谢尊金.全部耐药的短稳杆菌耐药机制的初步研究[J].中华医院感染学杂志,2005,15(10):1181-1182. 被引量:6
  • 3黄勇,陈秉孟,邓秋连,谢永强,张德纯.广州儿童医院重症监护病房感染病原菌的分布及耐药性分析[J].中国微生态学杂志,2006,18(3):219-221. 被引量:21
  • 4刘成军,陈应富,许峰,匡凤梧,陈沅,杨永弘.儿科重症监护病房细菌耐药性监测及分析[J].重庆医科大学学报,2007,32(9):959-962. 被引量:10
  • 5Allan ND, Bevefidge TJ. Gentamicin delivery to Burkholderia cepacia group Ilia strains via membrane vesicles from Pseudomonas aeruginosa PAOI [J]. Antimicrob Agents Chemother, 2003, 47 (9): 2962- 2965.
  • 6Chemish RN, Aaron SD. Approach to resistant gram - negative bacterial pulmonary infections in patients with cystic fibrosis [ J ]. Curr Opin Pulm Med, 2003, 9 (6): 509-515.
  • 7Dent LL, Marshall DR, Pratap S, et al. Multidrug resistant Aeineto- bacter baumannii: A descriptive study in a city hospital [ J ]. BMC Infectious Diseases, 2010, 10 (7): 196-203.
  • 8Detsika MG,Corkill JE,Magalh(a)es M,et al.Molecular typing of,and distribution of genetic markers among,burkholderia cepacia complex isolates from Brazil[J].J Clin Microbiol,2003,41(9):4148-4153.
  • 9Dizbay M,Tunccan OG,Sezer BE,et al.Nosoccomial Burkholderia cepacia infections in a Turkish university hospital:a five-year surveillance[J].J Infect Dev Ctries,2009,3(4):273-277.
  • 10Vandamme P,Dawyndt P.Classification and identification of the Burkholderia cepacia complex:Past,present and future[J].Syst Appl Microbiol,2011,34(2):87-95.

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部